GET THE APP
Monday, February 23, 2026

Tag: Albert Bourla
September 30, 2025
Jack Montgomery
Breaking
Health

BREAKING: Trump Strikes Pfizer Deal for Lower Prices, $70BN in Investment, and New ‘TrumpRx’ Drugs Site.

PULSE POINTS

âť“WHAT HAPPENED: President Donald J. Trump announced a deal with Pfizer to lower drug prices and increase investment in U.S. manufacturing, along with a new direct-to-consumer drug-buying website dubbed TrumpRx.

👤WHO WAS INVOLVED: PresidentTrump, Pfizer CEO Albert Bourla, and American patients.

đź“ŤWHEN & WHERE: Announcement made on Tuesday from the Oval Office.

đź’¬KEY QUOTE: “Pfizer is one of the biggest, greatest in the world.” – Donald Trump

🎯IMPACT: Pfizer shares increased by 3.5 percent following the announcement.

IN FULL

Americans will soon have the opportunity to purchase prescription drugs directly from a new government website, dubbed “TrumpRx,” which will provide discounted drugs to consumers. President Donald J. Trump and members of his administration announced the site at the same time as a deal with pharmaceutical giant Pfizer, cutting drug prices for Americans and securing $70 billion in investment.

While specifics on the prescriptions available on TrumpRx are still to be explained in detail, President Trump indicated that at least some of Pfizer’s drugs would be offered on the new platform. The America First leader, speaking alongside Pfizer CEO Albert Bourla, said that the U.S. will benefit from the “lowest price” globally under a most-favored-nations system, addressing the long-standing issue of American consumers subsidizing global research and development costs.

Bourla admitted that, until now, foreign governments have been allowing America to shoulder an unfair share of the burden in terms of funding research and development, and that President Trump’s tariffs have proved a powerful means of forcing reform.

Following the announcements, Pfizer’s stock saw a 3.5 percent increase, reflecting a positive market response to the deal.

This story is developing…

Join Pulse+ to comment below, and receive exclusive e-mail analyses.

show less
show more
October 23, 2024
Jack Montgomery
Health
Lawfare

Court Says Bill Gates Vaccine Case CAN Continue.

Bill Gates, the billionaire founder of Microsoft, is being sued in a Dutch court over his role in the global COVID-19 vaccination rollout. A group of vaccine-injured Dutch citizens blame Gates, Pfizer boss Albert Bourla, globalist former Prime Minister Mark Rutte—now NATO Secretary General—and other officials for their health issues.

The plaintiffs claim the vaccines, aggressively pushed by Gates and supported by Rutte’s government, have caused serious harm, and that the public was deliberately misled about their safety and effectiveness. Gates attempted to dodge the lawsuit by insisting Dutch judges have no authority over him, but a court in Leeuwarden has ruled it does have jurisdiction.

While Gates argued he does not reside in the Netherlands and has no direct connection to the plaintiffs, the court rejected this argument, noting the involvement of the Bill & Melinda Gates Foundation in distributing vaccines across the globe, including the Netherlands.

While corporate media and health technocrats have largely praised pandemic-era vaccines, the Dutch plaintiffs argue they were rushed, inadequately tested, and caused severe, underreported side effects.

Gates, who has positioned himself as a global health leader, has long faced accusations that his true motivations are driven by anti-natalist ideology and a desire for profits.

Image by United Nations / Jean-Marc Ferré.

show less
Bill Gates, the billionaire founder of Microsoft, is being sued in a Dutch court over his role in the global COVID-19 vaccination rollout. A group of vaccine-injured Dutch citizens blame Gates, Pfizer boss Albert Bourla, globalist former Prime Minister Mark Rutte—now NATO Secretary General—and other officials for their health issues. show more
November 2, 2023
William Upton
News

Speaker Johnson Hires Pfizer, Big Pharma Lobbyist.

Newly elected Speaker Mike Johnson (R-LA) has begun to fill critical positions in his leadership staff with former Republican Study Committee executive director Dan Ziegler tapped to serve as the Speaker’s policy director. While Ziegler’s tenure on Capitol Hill was fairly mundane, his post-Hill lobbying work will surely concern amongst conservatives.

Zielger, most recently a principal at the law firm and lobbyist group Williams and Jensen, has represented a bevy of bio-tech and pharmaceutical companies. Some of his most recognizable clients include the bio-tech firm Amgen, Pfizer, Eli Lilly, Merck, Ozempic maker Novo Nordisk, and PhRMA – the major pharmaceutical industry trade group. The lobbying work on behalf of Pfizer and PhRMA are especially concerning given the industry connections to the Democrat Party and anti-Trump, globalist causes.

Two months ago, Pfizer CEO Albert Bourla appeared at the Clinton Foundation’s “Clinton Global Initiative” alongside former British Prime Minister Tony Blair, U.S. Secretary of the Interior Deb Haaland, and California Governor Gavin Newsom. The annual conference serves as a major spring-board for globalist policy initiatives aimed to “implement solutions to the world’s most pressing challenges, including climate change, inclusive economic growth, and health equity.”

Last year, Pfizer sponsored the Atlantic magazine festival in Washington, D.C. which featured a whose-who of globalist movers-and-shakers. COVID-19 obsessed Dr. Anthony Fauci appeared alongside Ibram X. Kendi, former White House Chief of Staff Ron Klain, and Treasury Secretary Janet Yellen. Among the subjects discussed at the event were critical race theory, diversity, Ukraine, censorship, climate change, and centralizing healthcare and pandemic response control. Bourla was among over 150 multinational corporate leaders to sign a statement demanding evidence of election fraud during the 2020 presidential election be ignored and Joe Biden be installed as President.

Federal election records show Zielger contributed $1,000 to Florida Governor Ron DeSantis’s 2024 presidential campaign.

show less
Newly elected Speaker Mike Johnson (R-LA) has begun to fill critical positions in his leadership staff with former Republican Study Committee executive director Dan Ziegler tapped to serve as the Speaker's policy director. While Ziegler's tenure on Capitol Hill was fairly mundane, his post-Hill lobbying work will surely concern amongst conservatives. show more
October 16, 2023
Jake Welch
Health
News
Science

Pfizer Cuts Costs After Collapse In Vax Uptake.

Pfizer has been forced to reduce staff numbers and implement billion-dollar cuts in its operating costs following the collapse in COVID-19 vaccine and treatment sales over the past 12 months.

The pharmaceutical giant is set to cut costs by $1 billion this year and at least $2.5 billion in 2024 as its annual revenue has almost halved from over $100 billion last year, with Coronavirus vaccine sales making up $56 million of that figure, to around $60 billion in 2023. There is yet to be a confirmed figure regarding job losses, however.

The company also anticipates sales of its vaccine and Paxlovid, another coronavirus medication, to be $12.5 billion, roughly $9 billion lower than initially forecasted.

“We remain proud that our scientific breakthroughs played a significant role in getting the global health crisis under control,” said Pfizer’s chief executive, Albert Bourla, following the announcement.

“As we gain additional clarity around vaccination and treatment rates for COVID, we will be better able to estimate the appropriate level of supply to meet demand,” Bourla added.

The fall in demand for COVID-19 vaccines has also forced countries to scrap hundreds of millions of doses.

show less
Pfizer has been forced to reduce staff numbers and implement billion-dollar cuts in its operating costs following the collapse in COVID-19 vaccine and treatment sales over the past 12 months. show more